INSPRA
BGP PHARMA ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of INSPRA in Canada?
A shortage of INSPRA 25MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated November 9, 2026), but it has not started yet.
Why is INSPRA not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will INSPRA be available again?
The manufacturer's estimated resolution date is February 9, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
INSPRA
BGP PHARMA ULC
JAMP EPLERENONE
JAMP PHARMA CORPORATION
MINT-EPLERENONE
MINT PHARMACEUTICALS INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02323052
Strength
25MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.